from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1307/atpH

LFCtreatmentdescriptionclass of inhibitor

-1.169

Amikacinug/mL Amikacintranslation

-1.428

Cap5-10ug/mL Capreomycintranslation

-2.866

Rox10-50 ug/mL Roxithromycintranslation

0.013

SM2-5 ug/mL Streptomycintranslation

-2.352

Tet5-10 ug/mL Tetracyclinetranslation

0.220

Rif0.2-5ug/mL Rifampicintranscription

-0.152

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.096

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.111

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.557

CPZ10-50 ug/mL Chlorpromazinerespiration

0.897

Clofazimine10-13 ug/mL Clofaziminerespiration

0.638

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.585

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.034

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.511

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.534

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.296

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.282

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.757

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.661

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.374

KCN5-20 ug/mL Potassium cyaniderespiration

0.803

NaN30.2-2 mM Sodium aziderespiration

0.111

Nigericin50 uM Nigericinrespiration

-0.692

TRC10-150 ug/mL Triclosanrespiration

-1.801

TRZ10-25 ug/mL Thioridazinerespiration

-2.679

Valinomycin0.5-10 uM Valinomycinrespiration

0.328

ZnSO42 mM ZnSO4respiration

-1.152

menadione6-10 ug/mL Menadionerespiration

0.709

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.515

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.833

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.339

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.106

NRP_1Non-replicating persistence stage 1dosRassociated

0.544

Amp0.2mg/mL AmpicillincellWall

0.078

Cephalexin20-100 ug/mL CephalexincellWall

0.368

Cerulenin0.32-5 ug/mL CerulenincellWall

0.931

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.712

EMB10-20 ug/mL EthambutolcellWall

0.684

Eta12-40 ug/mL EthionamidecellWall

0.884

INH0.2-0.4 ug/mL IsoniazidcellWall

0.694

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.078

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.564

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.388

BZA0.12 mg/mL BenzamidearomaticAmides

0.223

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.046

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.022

H2O24 mM hydrogen peroxideDNAdamaging

0.667

Levo10 ug/mL LevofloxacinDNAdamaging

0.639

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.106

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.612

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.413

UVUV-irradiationDNAdamaging

-1.671

ARP41-4 ug/mL Antitubercular compound ARP4?

0.797

Antimycin12.5-50 ug/mL Antimycin A?

0.501

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.942

PA_110-50 ug/mL Antitubercular compound PA-1?

1.180

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.875

PA8240.2-2 ug/mL PA-824?

-0.201

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.232

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.430

Verapamil50 uM Verapamil?

0.265

mercaptoethanol2 mM 2-Mercaptoethanol?

0.446

methoxatin10-20 ug/mL Methoxatin?